Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 26.09.2019  
C(2019)  7045 final  
PUBLIC VERSION 
To the notifying parties  
Subject : Case M. 9525 -  EPE / OCH / OMNICARE  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 04 September 2019, the European Commission received notification of a proposed 
concentration pursuant to Article 4  of the Merger  Regulation by which Equistone 
Partners Europe Limited  (“Equistone”, United Kingdom ) and Mr. Oliver TAMIMI, 
through Omnicare Holding GmbH & Co. KG  (“OCH” , Germany) , acquire within the 
meaning of Article s 3(1)(b) and 3(4) of the Merger Regulation  joint control over 
Omnicare Beteiligungen GmbH  (“Omnicare”, Germany) by way of purchase of 
shares .3 Omnicare is currently exclusively controlled, through OCH, by Mr. Olivier 
TAMIMI.  
2. The business activities of the undertakings concerned are:  
− Equistone is a private equity investment firm active in the Unite d Kingdom, 
France, Germany and Switzerland. Funds controlled by Equistone are investing in 
companies from various business sectors such as consumer and travel, financial 
services, specialist engineering and support services ; 
− Mr. Oliver TAMIMI controls several economic undertakings, including notably 
(i) my Pharmacy Gmbh, which provides various services to pharmacies in 
Germany (e.g. accounting services and quality management), (ii) Sovelio, which 
is specialised in home care, and (iii) MP Immobilien, which owns and leases real 
estate in Munich;  
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union’  and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will b e used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 307, 11.09.2019 , p. 11. 

 
2 − Omnicare is mainly active in : (i) specialty pharma distribution  (oncological 
pharmaceutical products) , (ii) services for compounding pharmacies, (iii) holding 
of participations in certain  outpatient oncological medical centres  and (iv) clinics 
for treatment of mental and psych osomatic disorders and diseases.   
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No  139/2004.4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Com mission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission 
 
 
(Signed)  
Cecilio MADERO VILLAREJO  
Acting Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5.